- Home
- EWCZ vs LXRX Comparison
EWCZ vs LXRX Comparison
Compare EWCZ & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWCZ
- LXRX
- Stock Information
- Founded
- EWCZ 2004
- LXRX 1995
- Country
- EWCZ United States
- LXRX United States
- Employees
- EWCZ N/A
- LXRX N/A
- Industry
- EWCZ Package Goods/Cosmetics
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- EWCZ Consumer Discretionary
- LXRX Health Care
- Exchange
- EWCZ Nasdaq
- LXRX Nasdaq
- Market Cap
- EWCZ 248.8M
- LXRX 228.8M
- IPO Year
- EWCZ 2021
- LXRX 2000
- Fundamental
- Price
- EWCZ $5.67
- LXRX $0.75
- Analyst Decision
- EWCZ Buy
- LXRX Buy
- Analyst Count
- EWCZ 7
- LXRX 4
- Target Price
- EWCZ $5.86
- LXRX $3.67
- AVG Volume (30 Days)
- EWCZ 632.8K
- LXRX 3.8M
- Earning Date
- EWCZ 08-13-2025
- LXRX 07-31-2025
- Dividend Yield
- EWCZ N/A
- LXRX N/A
- EPS Growth
- EWCZ N/A
- LXRX N/A
- EPS
- EWCZ 0.21
- LXRX N/A
- Revenue
- EWCZ $216,469,000.00
- LXRX $31,213,000.00
- Revenue This Year
- EWCZ N/A
- LXRX N/A
- Revenue Next Year
- EWCZ $2.17
- LXRX N/A
- P/E Ratio
- EWCZ $27.59
- LXRX N/A
- Revenue Growth
- EWCZ N/A
- LXRX 1251.21
- 52 Week Low
- EWCZ $2.72
- LXRX $0.28
- 52 Week High
- EWCZ $11.03
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- EWCZ 56.58
- LXRX 61.01
- Support Level
- EWCZ $5.71
- LXRX $0.64
- Resistance Level
- EWCZ $5.82
- LXRX $0.77
- Average True Range (ATR)
- EWCZ 0.30
- LXRX 0.06
- MACD
- EWCZ -0.09
- LXRX 0.00
- Stochastic Oscillator
- EWCZ 43.10
- LXRX 76.47
About EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax. Its services include Brazilian Waxing, Brow Waxing, Body Waxing, Facial Waxing, All Waxing Services, Eyebrow Tinting, Laser Hair Removal, Men's Waxing Services and others.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.